Abstract
Authors argue that characterization of gene transfer research as "gene therapy" has compromised informed consent in the current environment of regulatory exceptions, routinized consent, fostered therapeutic misconceptions, and oversold research.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Advisory Committees
-
Beneficence
-
Disclosure
-
Ethics Committees, Research
-
Ethics, Medical
-
Federal Government
-
Genetic Research*
-
Genetic Therapy*
-
Government Regulation*
-
Human Experimentation*
-
Humans
-
Informed Consent*
-
Personal Autonomy
-
Research Subjects
-
Risk Assessment
-
Therapeutic Human Experimentation*
-
Trust
-
United States